You have selected the view in French
| Descriptor English: | Prazosin | ||||||
| Descriptor Spanish: |
Prazosina
| ||||||
| Descriptor Portuguese: | Prazosina | ||||||
| Descriptor French: | Prazosine | ||||||
| Tree number(s): |
D03.633.100.786.750 |
||||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D011224 | ||||||
| Scope note: | A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION. |
||||||
| Allowable Qualifiers: |
AA analogues et dérivés AD administration et posologie AE effets indésirables AG agonistes AI antagonistes et inhibiteurs AN analyse BL sang CF liquide cérébrospinal CH composition chimique CL classification CS synthèse chimique EC économie HI histoire IM immunologie IP isolement et purification ME métabolisme PD pharmacologie PK pharmacocinétique PO intoxication RE effets des radiations SD ressources et distribution ST normes TO toxicité TU usage thérapeutique UR urine |
||||||
| Pharm Action: |
Antihypertensive Agents Adrenergic alpha-1 Receptor Antagonists |
||||||
| Registry Number: | XM03YJ541D | ||||||
| CAS Type 1 Name: | Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)- | ||||||
| DeCS ID: | 22618 | ||||||
| Unique ID: | D011224 | ||||||
| NLM Classification: | QV 151 | ||||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
| Date Established: | 1986/01/01 | ||||||
| Date of Entry: | 1976/04/13 | ||||||
| Revision Date: | 2017/05/24 |
-
-
PRODUITS CHIMIQUES ET PHARMACEUTIQUES
Composés hétérocycliques [D03]Composés hétérocycliques
|
|
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
